Prescribed


Book Description

The first authoritative look at the history of the prescription itself, Prescribed is a groundbreaking book that subtly explores the politics of therapeutic authority and the relations between knowledge and practice in modern medicine.







A Text Book on Prescription Writing and Pharmacy


Book Description

Excerpt from A d104 Book on Prescription Writing and Pharmacy: With Practice in Prescription-Writing, Laboratory Exercises in Pharmacy, and a Reference List of the Official Drugs, Especially Designed for Medical Students The problems in prescription-writing introduced so abun dautly in this book are intended to serve as exercises of the first grade. They are expected to teach the student the best form in which medicines may be prescribed. After the student has mastered this course, he should be introduced to problems of the second grade, in which he should be required to pre scribe a certain drug or combination of drugs; leaving the choice of form, dose, and method of administration to the exercise of the student's knowledge and judgment. Finally, the student should be drilled in problems of a third grade, in which he is asked to prescribe for a certain condition of dis ease, for which he is to choose the proper medicament, which is then to be prescribed in the proper way. Thus, he advances by successive stages up to the point when he will be able to grapple successfully with the problems at the patient 's bedside, when the element of diagnosis is added as a final complication. Is it a wonder that young practitioners who have not had the training just outlined find themselves hopelessly lost when they are faced by the necessity of writing a prescription at the bedside. About the Publisher Forgotten Books publishes hundreds of thousands of rare and classic books. Find more at www.forgottenbooks.com This book is a reproduction of an important historical work. Forgotten Books uses state-of-the-art technology to digitally reconstruct the work, preserving the original format whilst repairing imperfections present in the aged copy. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in our edition. We do, however, repair the vast majority of imperfections successfully; any imperfections that remain are intentionally left to preserve the state of such historical works.







The Risks of Prescription Drugs


Book Description

Few people realize that prescription drugs have become a leading cause of death, disease, and disability. Adverse reactions to widely used drugs, such as psychotropics and birth control pills, as well as biologicals, result in FDA warnings against adverse reactions. The Risks of Prescription Drugs describes how most drugs approved by the FDA are under-tested for adverse drug reactions, yet offer few new benefits. Drugs cause more than 2.2 million hospitalizations and 110,000 hospital-based deaths a year. Serious drug reactions at home or in nursing homes would significantly raise the total. Women, older people, and people with disabilities are least used in clinical trials and most affected. Health policy experts Donald Light, Howard Brody, Peter Conrad, Allan Horwitz, and Cheryl Stults describe how current regulations reward drug companies to expand clinical risks and create new diseases so millions of patients are exposed to unnecessary risks, especially women and the elderly. They reward developing marginally better drugs rather than discovering breakthrough, life-saving drugs. The Risks of Prescription Drugs tackles critical questions about the pharmaceutical industry and the privatization of risk. To what extent does the FDA protect the public from serious side effects and disasters? What is the effect of giving the private sector and markets a greater role and reducing public oversight? This volume considers whether current rules and incentives put patients' health at greater risk, the effect of the expansion of disease categories, the industry's justification of high U.S. prices, and the underlying shifts in the burden of risk borne by individuals in the world of pharmaceuticals. Chapters cover risks of statins for high cholesterol, SSRI drugs for depression and anxiety, and hormone replacement therapy for menopause. A final chapter outlines six changes to make drugs safer and more effective. Suitable for courses on health and aging, gender, disability, and minority studies, this book identifies the Risk Proliferation Syndrome that maximizes the number of people exposed to these risks. Additional Columbia / SSRC books on the privatization of risk and its implications for Americans: Bailouts: Public Money, Private ProfitEdited by Robert E. Wright Disaster and the Politics of InterventionEdited by Andrew Lakoff Health at Risk: America's Ailing Health System-and How to Heal ItEdited by Jacob S. Hacker Laid Off, Laid Low: Political and Economic Consequences of Employment InsecurityEdited by Katherine S. Newman Pensions, Social Security, and the Privatization of RiskEdited by Mitchell A. Orenstein




Introduction to the Pharmacy Profession


Book Description

This book offers a career assessment tool as well as helpful tips on resume preparation, interviewing techniques, and obtaining an internship. Readers gain a real-world perspective on pharmacy practice through interviews with over 35 pharmacists from areas such as academia, public health, and retail pharmacy. These insightful testimonials describe practical job responsibilities and offer guidance on finding the right career path."--




Textbook Of Pharmacology


Book Description

About the Author : - SD Seth is currently Chair in Clinical Pharmacology at the ICMR and an honorary Advisor to the Clinical Trials Registry India. He has served as a faculty in AIIMS for 29 years. He is the founder member of the National Poisons Information Centre at AIIMS. Professor Seth is a member of several prestigious Committees like the Scientific Advisory Committee of the Drugs for Neglected Diseases Initiative, Geneva, Drugs Technical Advisory Board, Investigational New Drug Committee, National Pharmacovigilance Steering Committee, and other committees of ICMR, CSIR, DST, DBT and Ministry of Health.Vimlesh Seth has a teaching experience of 30 years at the Department of Paediatrics, AIIMS. She has been a recipient of the award James Flett Gold Medal for her work in growth and development of children. In addition, research work guided by her has been awarded the President's medal for the Indian Rheumatic Association, Dr Vaishnav Award and PV Sukhatam Award.




A History of the Medicines We Take


Book Description

A History of the Medicines We Take gives a lively account of the development of medicines from traces of herbs found with the remains of Neanderthal man, to prescriptions written on clay tablets from Mesopotamia in the third millennium BC, to pure drugs extracted from plants in the nineteenth century to the latest biotechnology antibody products. The first ten chapters of the book in PART ONE give an account of the development of the active drugs from herbs used in early medicine, many of which are still in use, to the synthetic chemical drugs and modern biotechnology products. The remaining eight chapters in PART TWO tell the story of the developments in the preparations that patients take and their inventors, such as Christopher Wren, who gave the first intravenous injection in 1656, and William Brockedon who invented the tablet in 1843. The book traces the changes in patterns of prescribing from simple dosage forms, such as liquid mixtures, pills, ointments, lotions, poultices, powders for treating wounds, inhalations, eye drops, enemas, pessaries and suppositories mentioned in the Egyptian Ebers papyrus of 1550 BCE to the complex tablets, injections and inhalers in current use. Today nearly three-quarters of medicines dispensed to patients are tablets and capsules. A typical pharmacy now dispenses about as many prescriptions in a working day as a mid-nineteenth- century chemist did in a whole year.




Medicating Modern America


Book Description

With Americans paying more than $200 billion each year for prescription pills, the pharmaceutical business is the most profitable in the nation. The popularity of prescription drugs in recent decades has remade the doctor/patient relationship, instituting prescription-writing and pill-taking as an integral part of medical practice and everyday life. Medicating Modern America examines the meanings behind this pharmaceutical revolution through the interconnected histories of eight of the most influential and important drugs: antibiotics, mood stabilizers, hormone replacement therapy, oral contraceptives, tranquilizers, stimulants, statins, and Viagra. All of these drugs have been popular, profitable, influential, and controversial, and the authors take a historical approach to studying their development, prescription, and consumption. This perspective locates the histories of prescription medicines in specific cultural contexts while revealing the extent to which contemporary debates about pharmaceutical drugs echo concerns voiced by Americans in the past. Exploring the rich and multi-faceted history of pharmaceutical drugs in the United States, Medicating Modern America unveils the untold stories behind America's pharmaceutical obsession. Contributors include: Robert Bud, Jennifer R. Fishman, Jeremy A. Greene, David Healy, Suzanne White Junod, Ilina Singh, Andrea Tone, and Elizabeth Siegel Watkins.